RA
CRL icon

Ransom Advisory’s Charles River Laboratories CRL Stock Holding History

Ransom Advisory’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$26.1K Hold
131
– – 0.01% 277
2025
Q3 		$20.5K Hold
131
– – 0.01% 224
2025
Q2 		$19.9K Hold
131
– – 0.01% 237
2025
Q1 		$19.7K Hold
131
– – 0.01% 247
2024
Q4 		$24.2K Sell
131
-35
-21% -$6.74K 0.01% 283
2024
Q3 		$32.7K Hold
166
– – 0.02% 262
2024
Q2 		$34.3K Buy
166
+96
+137% +$21.8K 0.02% 250
2024
Q1 		$19K Buy
+70
New +$16.7K 0.01% 249

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Ransom Advisory's CRL Position: Q4 2025 in Review

Ransom Advisory held its Charles River Laboratories (CRL) position steady in Q4 2025 at 131 shares worth $26.1K. The position accounts for 0.01% of the portfolio, ranked #277.

Ransom Advisory first reported a position in CRL in Q1 2024 and has held it in 8 quarters since. The position peaked at $34.3K in Q2 2024. 581 funds tracked by Wall St. Rank hold CRL as of Q4 2025.

  • Ransom Advisory held 131 shares of Charles River Laboratories worth $26.1K as of Q4 2025.
  • Ransom Advisory left its Charles River Laboratories share count unchanged in Q4 2025.
  • Charles River Laboratories made up 0.01% of Ransom Advisory's portfolio in Q4 2025, its #277 holding.
  • Ransom Advisory first reported a position in Charles River Laboratories in Q1 2024 and has held it in 8 quarters since.
  • Ransom Advisory's Charles River Laboratories position peaked at $34.3K in Q2 2024.
  • 581 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2025.

Based on Ransom Advisory's 13F filing for Q4 2025, filed 6 Jan 2026.